A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial / Sierra, J., Szer, J., Kassis, J., Herrmann, R., Lazzarino, M., Thomas, X., Noga, S.j., Baker, N., Dansey, R., Bosi, A.. - In: BMC CANCER. - ISSN 1471-2407. - STAMPA. - 8:(2008), pp. 195-199.
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.
BOSI, ALBERTO
2008
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
art%3A10.1186%2F1471-2407-8-195.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
352 kB
Formato
Adobe PDF
|
352 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
